Christian S. Schade
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christian S. Schade
Earlier roles on record: Chairman and Board Member at Aprea Therapeutics, Inc. (APRE) until August 23, 2023 and CEO at Aprea Therapeutics, Inc. (APRE) until May 17, 2022. Aprea Therapeutics, Inc. reported in an 8-K filed August 24, 2023 that Christian S. Schade resigned as Board of Directors, effective August 23, 2023. Aprea Therapeutics, Inc. reported in an 8-K filed August 24, 2023 that Christian S. Schade resigned as Chairperson of the Board, effective August 23, 2023. The proxy statement of Aprea Therapeutics, Inc. reports total compensation of $3,677,567 for Christian S. Schade in fiscal 2019, including a base salary of $446,360. Disclosed compensation is on record for 2 fiscal years.
“On August 23, 2023, Christian S. Schade resigned from the Board of Directors (the "Board") of Aprea Therapeutics, Inc. (the "Company"), including as Chairperson of the Board and any respective committee of the Board to which he was a member, effective immediately.”
“On August 23, 2023, Christian S. Schade resigned from the Board of Directors (the "Board") of Aprea Therapeutics, Inc. (the "Company"), including as Chairperson of the Board and any respective committee of the Board to which he was a member, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-09-16–2023-08-23
-
2016-01-01–2023-08-23
-
Start not stated–2022-05-17
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Aprea Therapeutics, Inc. (APRE) | President and Chief Executive Officer | $446,360 | $3,677,567 |
| 2018 | Aprea Therapeutics, Inc. (APRE) | President and Chief Executive Officer | $412,000 | $593,280 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.